The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Risk-based treatment for nonrhabdomyosarcoma soft tissue sarcomas (NRSTS) in patients under 30 years of age: Children’s Oncology Group study ARST0332.
Sheri L. Spunt
No relevant relationships to disclose
Lynn Million
No relevant relationships to disclose
James Robert Anderson
No relevant relationships to disclose
Cheryl M. Coffin
No relevant relationships to disclose
Beth McCarville
No relevant relationships to disclose
R. Lor Randall
No relevant relationships to disclose
David Parham
No relevant relationships to disclose
Simon C Kao
No relevant relationships to disclose
Andrea Anita Hayes-Jordan
No relevant relationships to disclose
Suzanne L. Wolden
No relevant relationships to disclose
Stephanie Alicia Terezakis
No relevant relationships to disclose
Jennifer Black
No relevant relationships to disclose
Fran Laurie
No relevant relationships to disclose
Ellen Kawashima
No relevant relationships to disclose
Rose Anne Speights
No relevant relationships to disclose
Stephen Skapek
No relevant relationships to disclose
William H. Meyer
No relevant relationships to disclose
Douglas S. Hawkins
No relevant relationships to disclose
Alberto S. Pappo
No relevant relationships to disclose